FIELD: medicine; pharmacology.
SUBSTANCE: invention relates to medicine, in particular to pharmacology and pharmacy, specifically to a pharmaceutical composition based on 1-hydroxy-4-cyclohexylaminoadamantane hydrochloride and sodium salt of 4-hydroxybutyric acid, that has the ability to increase mental and physical performance under conditions of desynchronosis, characterized by, containing the active ingredient 1-hydroxy-4-cyclohexylaminoadamantane hydrochloride and 4-hydroxybutyric acid sodium salt and pharmaceutically acceptable target additives, suitable for use in solid dosage form, selected from the groups of excipients: fillers, disintegrants, binders, sliding substances and film coatings, with a certain ratio of these components.
EFFECT: composition is made in the form of tablets and contains the optimal amount of auxiliary substances.
3 cl, 6 dwg, 11 ex, 5 tbl
Title | Year | Author | Number |
---|---|---|---|
REMEDY FOR SEASONAL DESYNCHRONOSIS CORRECTION | 2017 |
|
RU2674337C1 |
TOOLS FOR CORRECTING THE DESYNCHRONOSIS CAUSED BY A DISTURBANCE IN THE LIGHT REGIME | 2017 |
|
RU2660578C1 |
MEANS OF CORRECTION AND PREVENTION OF CONDITIONS CAUSED BY VIOLATION OF DAILY RHYTHMS | 2017 |
|
RU2655813C1 |
METHOD FOR SLEEP NORMALIZATION | 2002 |
|
RU2218933C2 |
CHRONO-BIOLOGICAL CORRECTION AGENT | 2015 |
|
RU2601894C1 |
4-(1-HYDROXY-1-METHYL-2-MORPHOLINOETHYL)BENZOIC AND 4-(1-HYDROXY-2-MORPHOLINOCYCLOHEXYL)BENZOIC ACIDS, THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, ESTERS, POSSESSING ANXIOLYTIC ACTIVITY, AND METHOD OF OBTAINING THEREOF | 2012 |
|
RU2505536C1 |
ANTIDEPRESSANT, ANXIOLYTIC, NEUROPROTECTIVE AND IMMUNOSTIMULATING AGENT | 2010 |
|
RU2429834C1 |
NEW COMBINATIONS OF H3 RECEPTOR ANTAGONISTS AND NOREPINEPHRINE REUPTAKE INHIBITORS AND THEIR THERAPEUTIC USE | 2019 |
|
RU2809163C2 |
PHARMACEUTICAL COMPOSITION FOR SLEEP DISORDERS PREVENTION AND TREATMENT | 2016 |
|
RU2620855C1 |
METHOD FOR CORRECTION OF BEHAVIORAL DISORDERS IN EXPERIMENTAL DESYNCHRONOSIS UNDER CONDITIONS OF LED LIGHTING | 2016 |
|
RU2611392C1 |
Authors
Dates
2018-12-07—Published
2016-11-28—Filed